125 related articles for article (PubMed ID: 27453271)
1. Association between miR-499 rs3746444 and the susceptibility of hepatocellular carcinoma.
Yu H; Wang Y; Wang S; Sun N
Cell Mol Biol (Noisy-le-grand); 2016 Jun; 62(7):42-5. PubMed ID: 27453271
[TBL] [Abstract][Full Text] [Related]
2. MiR-499 rs3746444 polymorphism and hepatocellular carcinoma risk: A meta-analysis.
Qiu D; Han F; Zhuang H
J Cancer Res Ther; 2018 Jun; 14(Supplement):S490-S493. PubMed ID: 29970712
[TBL] [Abstract][Full Text] [Related]
3. rs3746444 polymorphism and susceptibility to hepatocellular carcinoma: evidence from published studies.
Liu F; Lin H; Cheng Y; Yang L; Liu Y
Cell Biochem Biophys; 2014 Dec; 70(3):1957-61. PubMed ID: 25074528
[TBL] [Abstract][Full Text] [Related]
4. Study of the association between five polymorphisms and risk of hepatocellular carcinoma: A meta-analysis.
Yu JY; Hu F; Du W; Ma XL; Yuan K
J Chin Med Assoc; 2017 Apr; 80(4):191-203. PubMed ID: 28188097
[TBL] [Abstract][Full Text] [Related]
5. Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: a systematic review and meta-analysis.
Xu Y; Li L; Xiang X; Wang H; Cai W; Xie J; Han Y; Bao S; Xie Q
Gene; 2013 Sep; 527(2):584-93. PubMed ID: 23791656
[TBL] [Abstract][Full Text] [Related]
6. Functional miR-146a, miR-149, miR-196a2 and miR-499 polymorphisms and the susceptibility to hepatocellular carcinoma: An updated meta-analysis.
Zheng L; Zhuang C; Zhao J; Ming L
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):664-676. PubMed ID: 28499985
[TBL] [Abstract][Full Text] [Related]
7. [Association between miR-146a single nucleotide polymorphism and genetic susceptibility to hepatocellular carcinoma: a meta-analysis].
Zhang LH; Zhang CY; Dai XZ; Zhang J; Zhang F
Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):749-754. PubMed ID: 29108203
[No Abstract] [Full Text] [Related]
8. Meta-analysis of the relationship between microRNA-499 rs3746444 polymorphism and hepatocellular carcinoma risk in Asians.
Wang W; Qin H; Zhou L; Ma J
J Cancer Res Ther; 2016; 12(2):676-80. PubMed ID: 27461631
[TBL] [Abstract][Full Text] [Related]
9. [A meta-analysis of microRNA-149, microRNA-499 gene polymorphism and susceptibility to hepatocellular carcinoma].
Ye LX; Fu CW; Jiang F; Cui YX; Meng W
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 May; 50(5):445-50. PubMed ID: 27141902
[TBL] [Abstract][Full Text] [Related]
10. Association study of two inflammation-related polymorphisms with susceptibility to hepatocellular carcinoma: a meta-analysis.
Liu J; Xie B; Chen S; Jiang F; Meng W
BMC Med Genet; 2014 Aug; 15():92. PubMed ID: 25108400
[TBL] [Abstract][Full Text] [Related]
11. The association between two common polymorphisms in MicroRNAs and hepatocellular carcinoma risk in Asian population.
Hu M; Zhao L; Hu S; Yang J
PLoS One; 2013; 8(2):e57012. PubMed ID: 23437296
[TBL] [Abstract][Full Text] [Related]
12. miR-146a rs2910164 and hepatocellular carcinoma: a meta-analysis.
Dong S; Miao AY; Lei W; Chen QW
Minerva Med; 2017 Jun; 108(3):287-292. PubMed ID: 27886162
[TBL] [Abstract][Full Text] [Related]
13. Interferon-γ +874A/T polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Zhou H; Wang L; Li X; Song J; Jiang T; Wu X; Zhou S
Med Sci Monit; 2015 Mar; 21():689-93. PubMed ID: 25739411
[TBL] [Abstract][Full Text] [Related]
14. Single nucleotide polymorphisms of MIR-149 gene rs2292832 contributes to the risk of hepatocellular carcinoma, but not overall cancer: a meta-analysis.
Jia H; Yu H; Liu Q
Minerva Med; 2016 Aug; 107(4):259-69. PubMed ID: 27348444
[TBL] [Abstract][Full Text] [Related]
15. Lack of association of two common polymorphisms rs2910164 and rs11614913 with susceptibility to hepatocellular carcinoma: a meta-analysis.
Wang Z; Cao Y; Jiang C; Yang G; Wu J; Ding Y
PLoS One; 2012; 7(6):e40039. PubMed ID: 22768213
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-12B+1188A/C polymorphism contributes to increased hepatocellular carcinoma susceptibility: evidence from a meta-analysis.
Peng Q; Li S; Lao X; Chen Z; Li R; Qin X
Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):735-43. PubMed ID: 25445750
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the value of miR-21 in the diagnosis of early stage HCC and its prognosis: a meta-analysis.
Yan SR; Liu ZJ; Yu S; Bao YX
Genet Mol Res; 2015 Sep; 14(3):11573-86. PubMed ID: 26436398
[TBL] [Abstract][Full Text] [Related]
18. miR-499A>G rs3746444 and miR-146aG>C expression and hepatocellular carcinoma risk in the Chinese population.
Shan YF; Huang YH; Chen ZK; Huang KT; Zhou MT; Shi HQ; Song QT; Yu ZP; Deng AM; Zhang QY
Genet Mol Res; 2013 Nov; 12(4):5365-71. PubMed ID: 24301908
[TBL] [Abstract][Full Text] [Related]
19. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
[TBL] [Abstract][Full Text] [Related]
20. MiR-146a and miR-196a-2 polymorphisms are associated with hepatitis virus-related hepatocellular cancer risk: a meta-analysis.
Tian T; Wang M; Zhu W; Dai ZM; Lin S; Yang PT; Liu XH; Liu K; Zhu YY; Zheng Y; Liu M; Dai ZJ
Aging (Albany NY); 2017 Jan; 9(2):381-392. PubMed ID: 28148887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
